Orion Peptides relaunches online store for research supply

Orion Peptides, an Austin-based supplier of research-grade peptides, has relaunched its online store at orionpeptide.com with a redesigned ordering platform and expanded catalog.

Austin, United States, October 16, 2026 -- Company announces relaunch of online store

Austin, TX — Orion Peptides, a supplier of research-grade peptides founded in January 2026 and based in Austin, announced the relaunch of its redesigned online store at orionpeptide.com. The updated platform introduces a streamlined ordering experience and account-based checkout designed for laboratory and academic researchers. The relaunch coincides with the company's effort to expand its research catalog and streamline fulfillment for the scientific community.

Redesigned platform and ordering experience

The new website features a simplified interface that allows researchers to browse products, manage accounts, and complete purchases with fewer steps. Account-based checkout is intended to support repeat orders and order history tracking for institutional and independent buyers. According to the company, the redesign focuses on reliability and clarity for users who require documented specifications and consistent product information.

Research catalog and product availability

Orion Peptides maintains a catalog of research-grade peptides, including BPC-157 and TB-500, supplied strictly for laboratory and scientific research use. All products are intended for in-vitro and laboratory research applications only. The company states that its catalog is developed to meet the documentation and quality expectations of academic and independent research settings.

Quality control and fulfillment commitments

The company emphasizes quality control, transparency, and reliable US fulfillment as core operational priorities. Orion Peptides reports that it provides batch documentation and product information to support research reproducibility. Orders are fulfilled from within the United States, with reliable shipping options available to domestic customers.

Company statement

A spokesperson for Orion Peptides said, "Our focus is on providing researchers with consistent, well-documented research materials and a purchasing process that respects their time. Transparency in sourcing and quality control is central to how we serve the research community, and the relaunched store reflects that commitment."

Availability and intended use

The relaunched store is available at orionpeptide.com. Orion Peptides states that all products are supplied for research purposes only and are not for human or veterinary use. The company does not make any health, medical, or therapeutic claims regarding its products, and no dosing or human outcome information is provided. Researchers are expected to comply with applicable institutional and regulatory requirements.

All Orion Peptides products are intended for research purposes only and are not intended for human consumption, diagnosis, treatment, cure or prevention of any disease.

About Orion Peptides

Orion Peptides is an Austin-based supplier of research-grade peptides founded in January 2026. The company serves academic researchers, independent laboratories, and research institutions with a catalog that includes BPC-157 and TB-500, supplied strictly for laboratory and scientific research use only. Orion Peptides focuses on quality control, transparency, and reliable US fulfillment. For more information, visit orionpeptide.com.

Contact Info:
Name: David Clarke
Email: Send Email
Organization: Orion
Address: 123 Research Blvd, Austin, TX
Phone: 5137094668
Website: https://orionpeptide.com/

Release ID: 89206339

Should you come across any errors, concerns, or inconsistencies within this press release's content, we urge you to reach out without delay by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will promptly address your feedback within 8 hours and take appropriate measures to resolve any identified issues or guide you through the removal process. Providing accurate and dependable information remains our utmost priority.